Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Zhou Y, Khan H, Xiao J, Cheang WS
This new class of drug, as it lowers obesity, has the potential to lower the use of every other drug that is used to treat obesity-related conditions, he added.
Two investigators (HW and TG) independently performed the data extraction from each publication using a standardized form: publication data, baseline characteristics of the study population (sample size, sex, age, body mass index (BMI), body weight, abdominal circumference, waist-to-hip ratio, visceral adipose tissue (measured by computed tomography, magnetic resonance imaging, or dual-emission X-ray absorptiometry)), duration of follow-up, weight change during treatment and after treatment discontinuation, description of the weight management group and control group
Results develop gradually over months, not weeks, making patience and persistence crucial factors
